BioAdvance News

Immunome Raises $5 Million Series A Financing to Advance Novel Cancer Immunotherapies

By WebmasterApril 20, 2016November 1st, 2024No Comments

Immunome Raises $5 Million Series A Financing to Advance Novel Cancer Immunotherapies

Previous PostRelmada Therapeutics Announces Results of In Vivo Study Showing d-Methadone has Antidepressant-like Effects
Next PostCohero Health and Presspart Group Announce Completion of Connected Metered Dose Inhaler